|Dermira Inc -- USA Stock|| |
USD 9.10 0.16 1.79%
Co-Founder and VP of Corporate Devel. and Strategy
Mr. Christopher M. Griffith is Senior Vice President Corporationrationrate Development and Strategy, Founder of the Company. He founded our company in August 2010 and has served as our Senior Vice President of Corporationrationrate Development and Strategy since January 2017, after previously serving as our Vice President of Corporationrationrate Development and Strategy since August 2011 and Head of Corporationrationrate Development and Strategy since September 2010. From July 2005 to September 2010, Mr. Griffith worked in corporate development at Gilead Sciences, Inc., most recently as Associate Director of Corporationrationrate Development. From May 2004 to August 2004, Mr. Griffith worked in the biooncology strategy group at Genentech, Inc., a biotechnology company. From 2001 to 2003, Mr. Griffith worked at Bay City Capital
Age: 39 Founder Since 2017 MBA
Griffith received B.S. and M.S. degrees in biological sciences from Stanford University and an M.B.A. degree from Harvard Business School.
Christopher Griffith Latest Insider Activity
The company has return on total asset (ROA)
of (24.58) %
which means that it has lost $24.58 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (152.77) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 279.39 M in liabilities with Debt to Equity (D/E) ratio of 186.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Dermira Inc has Current Ratio of 5.17 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Dermira, Inc., a biopharmaceutical company, identifies, develops, and commercializes therapies to treat dermatologic diseases. Dermira, Inc. was founded in 2010 and is headquartered in Menlo Park, California. Dermira operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 162 people.Dermira Inc (DERM) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 162 people. Dermira is listed under Pharmaceutical Products category by Fama And French industry classification.